The month of May started with a very important ESG milestone: Linnea received confirmation of its continued participation in the Energy Agency of the Swiss Private Sector (AEnEC) programme also for 2026.
Since 2015, Linnea has been part of this long-term target agreement, committed to improving energy efficiency and reducing greenhouse gas emissions through the implementation of defined measures over time. Progress is monitored and reviewed on an annual basis.
This continued engagement reflects our ongoing commitment as a pharmaceutical manufacturer to sustainable production and continuous environmental improvement.